<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18810" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Candidemia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mora Carpio</surname>
            <given-names>Andres L.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Climaco</surname>
            <given-names>Antonette</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Andres Mora Carpio declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Antonette Climaco declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>2</day>
          <month>9</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18810.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Candidemia is a&#x000a0;serious infection characterized by&#x000a0;<italic toggle="yes">Candida</italic>&#x000a0;spp in the bloodstream, diagnosed by&#x000a0;positive blood cultures from a peripheral or central line. As the fourth most common healthcare-associated bloodstream infection in the United States and the leading fungal bloodstream infection globally, candidemia presents significant clinical challenges. The incidence of healthcare-associated candidemia has risen by over 50% in the last decade, with high morbidity and mortality rates attributed to factors such as indwelling catheters, patient frailty, immunosuppression, overuse of antibiotics, delayed diagnosis, and variability in antifungal susceptibility. The disease can cause invasive candidiasis, leading to complications such as deep-seated tissue infections and severe bloodstream infections, contributing to prolonged hospital stays and increased healthcare costs.</p>
        <p>This educational activity for healthcare professionals offers crucial knowledge on the epidemiology, diagnosis, and management of candidemia, emphasizing the importance of early recognition, knowledge of local and global epidemiology, and the appropriate treatment to improve patient outcomes.&#x000a0;Healthcare professionals can better address the evolving epidemiology of<italic toggle="yes">&#x000a0;Candida</italic>&#x000a0;spp by learning to identify candidemia and manage antifungal therapy promptly. This activity also highlights the role of interprofessional collaboration, demonstrating how coordinated efforts among infectious disease specialists, microbiologists, pharmacists, and critical care teams can enhance the accuracy of diagnosis, streamline treatment, and ultimately improve patient care and survival rates.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the clinical signs and symptoms of candidemia, including risk factors such as indwelling catheters and immunosuppression.</p></list-item><list-item><p>Apply evidence-based antifungal treatment protocols and adjust therapy based on <italic toggle="yes">Candida</italic> spp susceptibility profiles.</p></list-item><list-item><p>Differentiate candidemia from other types of bloodstream and fungal infections to ensure accurate diagnosis and treatment.</p></list-item><list-item><p>Implement interprofessional team strategies for improving care coordination and communication&#x000a0;care for patients with candidemia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18810&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18810">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-18810.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p><italic toggle="yes">Candida</italic> spp are commensal yeasts that are normally found on&#x000a0;human skin, in mucosal and intestinal microbiota, and in the mycobiome. Still, these fungi can&#x000a0;become pathogenic and opportunistic if the appropriate circumstances are present.<xref ref-type="bibr" rid="article-18810.r1">[1]</xref> The human mycobiome makes up less than 0.1% of the intestinal microbiome, and up to 60% of people can be colonized with <italic toggle="yes">Candida</italic> spp.<xref ref-type="bibr" rid="article-18810.r2">[2]</xref>&#x000a0;<italic toggle="yes">Candida</italic>&#x000a0;spp can become pathogenic when the equilibrium between commensal organisms is disturbed, and risk factors for <italic toggle="yes">Candida </italic>spp overgrowth and invasiveness are present. Such risk factors include immunosuppression, the presence of central lines, and exposure to antibiotics.&#x000a0;<italic toggle="yes">Candida </italic>spp&#x000a0;can cause invasive and deep-seated candidiasis&#x000a0;via&#x000a0;the dissemination of <italic toggle="yes">Candida</italic> spp to sterile parts of the body, such as the peritoneum.<xref ref-type="bibr" rid="article-18810.r3">[3]</xref></p>
        <p>Precise global epidemiological data is lacking, but studies from the United States report that candidemia is the fourth most common healthcare-associated bloodstream infection (BSI) and the most common fungal BSI in patients who are hospitalized.<xref ref-type="bibr" rid="article-18810.r2">[2]</xref><xref ref-type="bibr" rid="article-18810.r4">[4]</xref><xref ref-type="bibr" rid="article-18810.r5">[5]</xref>&#x000a0;Candidemia is generally defined as&#x000a0;the presence of <italic toggle="yes">Candida</italic> spp in the blood; more precisely, it is defined as the presence of&#x000a0;<italic toggle="yes">Candida</italic> spp in "at least 1 positive blood culture from a peripheral or a central line."<xref ref-type="bibr" rid="article-18810.r2">[2]</xref>&#x000a0;Candidemia is associated with poorer patient outcomes, longer hospital stays, and increased healthcare costs&#x02014;and carries an&#x000a0;attributable mortality rate&#x000a0;that varies from 35% to 70%.<xref ref-type="bibr" rid="article-18810.r1">[1]</xref><xref ref-type="bibr" rid="article-18810.r6">[6]</xref></p>
        <p>Although <italic toggle="yes">C albicans</italic> is still the most common <italic toggle="yes">Candida&#x000a0;</italic>species to cause candidemia, there has been an increased incidence of BSI&#x000a0;with nonalbicans <italic toggle="yes">Candida</italic> spp, which have different&#x000a0;epidemiology and antifungal susceptibility profiles.<xref ref-type="bibr" rid="article-18810.r1">[1]</xref><xref ref-type="bibr" rid="article-18810.r7">[7]</xref> In addition, the emergence of <italic toggle="yes">C auris,</italic>&#x000a0;presents a novel, multidrug-resistant <italic toggle="yes">Candida</italic> spp. This changing epidemiology can result in difficulties when selecting the correct antifungal medication,&#x000a0;causing delays in treatment, which is associated with poor patient outcomes and higher attributable mortality.<xref ref-type="bibr" rid="article-18810.r1">[1]</xref><xref ref-type="bibr" rid="article-18810.r8">[8]</xref>&#x000a0;Managing candidemia should include immediate blood cultures, focus on the prompt selection and administration of appropriate antifungal therapy with adjustment of antifungals when necessary, removal of indwelling vascular devices if possible, documentation of clearing of blood cultures, and ensuring that the candidemia has not seeded remote sites, leading to complications.<xref ref-type="bibr" rid="article-18810.r9">[9]</xref></p>
      </sec>
      <sec id="article-18810.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">Candida </italic>is a group of&#x000a0;budding, white colony-forming yeasts that belong to the subphylum Saccharomycotina.<xref ref-type="bibr" rid="article-18810.r10">[10]</xref> They are commensal yeasts that are present as normal flora in humans on the skin and in mucosal surfaces, such as the gut microbiota, vagina, and mouth. Up to 60% of people are colonized with <italic toggle="yes">Candida</italic> spp, which is a prerequisite for developing an infection when risk factors exist.<xref ref-type="bibr" rid="article-18810.r2">[2]</xref></p>
        <p>Many<italic toggle="yes">&#x000a0;Candida</italic>&#x000a0;species exist, but certain species are most commonly associated with invasive infections.<xref ref-type="bibr" rid="article-18810.r1">[1]</xref>&#x000a0;Each <italic toggle="yes">Candida</italic> spp has unique behavioral properties and virulence, and the epidemiology can differ by country, healthcare system, and host risk factors.<xref ref-type="bibr" rid="article-18810.r11">[11]</xref>&#x000a0;<italic toggle="yes">Candida albicans&#x000a0;</italic>is the most common cause of candidemia worldwide, and the other species most commonly associated with invasive infections are&#x000a0;<italic toggle="yes">C glabrata (</italic>renamed to<italic toggle="yes">&#x000a0;<italic toggle="yes">Nakaseomyces glabrata)</italic>, C parapsilosis, C tropicalis, C krusei </italic>(renamed<italic toggle="yes">&#x000a0;<italic toggle="yes">Pichia kudriavzevii</italic></italic>),<italic toggle="yes"><italic toggle="yes">&#x000a0;</italic></italic>and&#x000a0;the&#x000a0;recently emerged<italic toggle="yes">&#x000a0;C auris&#x02014;</italic>whose occurrence is increasing worldwide<italic toggle="yes">.</italic><xref ref-type="bibr" rid="article-18810.r1">[1]</xref><xref ref-type="bibr" rid="article-18810.r8">[8]</xref><xref ref-type="bibr" rid="article-18810.r10">[10]</xref></p>
      </sec>
      <sec id="article-18810.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Candidemia is a public health concern because it is associated with poor patient outcomes, longer hospital stays, increased healthcare costs, and carries an&#x000a0;attributable mortality rate&#x000a0;that varies from 35% to 70%.<xref ref-type="bibr" rid="article-18810.r1">[1]</xref><xref ref-type="bibr" rid="article-18810.r6">[6]</xref>&#x000a0;Results from a recent study reported the 30-day overall mortality associated with candidemia to be 64%.<xref ref-type="bibr" rid="article-18810.r12">[12]</xref>&#x000a0;C<italic toggle="yes">andida</italic>&#x000a0;spp are commensal yeasts that are part of normal human skin, mucosal, intestinal microbiota, and mycobiome, but they can&#x000a0;become pathogenic and opportunistic if the appropriate circumstances are present.<xref ref-type="bibr" rid="article-18810.r1">[1]</xref>&#x000a0;The human mycobiome makes up less than 0.1% of the intestinal microbiome.&#x000a0;<italic toggle="yes">Candida</italic>&#x000a0;spp are a part of this biome, and up to 60% of people can be colonized with&#x000a0;<italic toggle="yes">Candida</italic>&#x000a0;spp.<xref ref-type="bibr" rid="article-18810.r2">[2]</xref>&#x000a0;<italic toggle="yes">Candida</italic>&#x000a0;spp can become pathogenic when the equilibrium between commensal organisms is disturbed, and risk factors for&#x000a0;<italic toggle="yes">Candida</italic>&#x000a0;overgrowth, invasiveness, and translocation of the organism are present. This combination of colonization and the presence of risk factors can&#x000a0;lead to invasive and deep-seated candidiasis, which includes&#x000a0;candidemia.<xref ref-type="bibr" rid="article-18810.r3">[3]</xref>. Risk factors predisposing one to the development of infection include critical illness, prolonged intensive care unit stay, an indwelling central venous catheter, cancer, transplantation, exposure to antibiotics, abdominal surgery, immunosuppression, malignancy, and total parenteral nutrition.<xref ref-type="bibr" rid="article-18810.r13">[13]</xref><xref ref-type="bibr" rid="article-18810.r14">[14]</xref><xref ref-type="bibr" rid="article-18810.r15">[15]</xref>&#x000a0;</p>
        <p>In general, complete epidemiological data from all countries, geographic areas, patient populations, and healthcare systems are lacking. Directly comparing data from studies and surveillance systems can be&#x000a0;challenging because different definitions for the denominators are used, and incidence rates may fluctuate even within countries and years.<xref ref-type="bibr" rid="article-18810.r3">[3]</xref>&#x000a0;Candidemia is one of the most common healthcare-associated BSI globally in at-risk patients, especially in those patients who require intensive care.<xref ref-type="bibr" rid="article-18810.r13">[13]</xref><xref ref-type="bibr" rid="article-18810.r14">[14]</xref><xref ref-type="bibr" rid="article-18810.r15">[15]</xref>&#x000a0;</p>
        <p>Candidemia is the most common&#x000a0;fungal BSI in hospitalized patients in the United States (US) and Europe and is the fourth&#x000a0;most common healthcare-associated BSI in the US.<xref ref-type="bibr" rid="article-18810.r2">[2]</xref><xref ref-type="bibr" rid="article-18810.r4">[4]</xref><xref ref-type="bibr" rid="article-18810.r5">[5]</xref>&#x000a0;Although&#x000a0;<italic toggle="yes">C&#x000a0;albicans</italic>&#x000a0;is still the most common&#x000a0;<italic toggle="yes">Candida&#x000a0;</italic>species to cause candidemia, there has been a shift in the species distribution&#x000a0;of BSI in recent years, and nonalbicans&#x000a0;species such as&#x000a0;<italic toggle="yes">C glabrata,&#x000a0;C parapsilosis, </italic>and<italic toggle="yes">&#x000a0;C tropicalis</italic> have been more frequently isolated.<xref ref-type="bibr" rid="article-18810.r16">[16]</xref>&#x000a0;In the US, <italic toggle="yes">C glabrata </italic>is the second most common nonalbicans <italic toggle="yes">Candida</italic> spp to cause candidemia,&#x000a0;followed by&#x000a0;<italic toggle="yes">C tropicalis&#x000a0;</italic>and<italic toggle="yes">&#x000a0;C parapsilosis.&#x000a0;</italic>The group containing nonalbicans&#x000a0;<italic toggle="yes">Candida</italic>&#x000a0;spp&#x000a0;has emerged as the most frequently isolated species, higher than <italic toggle="yes">C albicans</italic>.<xref ref-type="bibr" rid="article-18810.r13">[13]</xref><xref ref-type="bibr" rid="article-18810.r14">[14]</xref><xref ref-type="bibr" rid="article-18810.r17">[17]</xref><xref ref-type="bibr" rid="article-18810.r18">[18]</xref>&#x000a0;<italic toggle="yes">Candida glabrata</italic>&#x000a0;is the&#x000a0;second most commonly reported from the US, Northern Europe, and Australia, while&#x000a0;<italic toggle="yes">C parapsilosis</italic>&#x000a0;is the most prevalent nonalbicans species in Latin America, Southern Europe, and Asia.<xref ref-type="bibr" rid="article-18810.r16">[16]</xref><xref ref-type="bibr" rid="article-18810.r19">[19]</xref>&#x000a0;</p>
        <p>The increasing incidence of BSI with nonalbicans&#x000a0;<italic toggle="yes">Candida</italic>&#x000a0;spp&#x000a0;is concerning because these&#x000a0;<italic toggle="yes">Candida</italic> spp&#x000a0;have different&#x000a0;epidemiological and antifungal susceptibility profiles compared to <italic toggle="yes">C albicans</italic>&#x000a0;and can display&#x000a0;varied acquired and inherent susceptibility to antifungals.<xref ref-type="bibr" rid="article-18810.r1">[1]</xref><xref ref-type="bibr" rid="article-18810.r7">[7]</xref><xref ref-type="bibr" rid="article-18810.r20">[20]</xref>&#x000a0;Resistance to fluconazole, frequently associated with exposure to the drug, has been well-documented&#x000a0;in<italic toggle="yes"> C albicans</italic><italic toggle="yes">.</italic>&#x000a0;Although&#x000a0;it is&#x000a0;currently low in geographic regions such as the US and other regions, this may change with increased use of fluconazole.<xref ref-type="bibr" rid="article-18810.r17">[17]</xref>&#x000a0;The true prevalence of resistance of <italic toggle="yes">C albicans</italic> to fluconazole is unknown, but increasing resistance to this drug is worrisome because it is the most frequently prescribed antifungal for <italic toggle="yes">Candida</italic> infections.<xref ref-type="bibr" rid="article-18810.r17">[17]</xref>&#x000a0;Certain nonalbicans species, including&#x000a0;<italic toggle="yes">C glabrata&#x000a0;</italic>and<italic toggle="yes"> C parapsilosis,</italic> may display&#x000a0;higher rates of resistance to&#x000a0;fluconazole than <italic toggle="yes">C albicans,&#x000a0;</italic>and<italic toggle="yes"> C kruzei </italic>is inherently resistant to fluconazole.<xref ref-type="bibr" rid="article-18810.r1">[1]</xref><xref ref-type="bibr" rid="article-18810.r7">[7]</xref><xref ref-type="bibr" rid="article-18810.r20">[20]</xref><xref ref-type="bibr" rid="article-18810.r21">[21]</xref>&#x000a0;This changing epidemiology can result in difficulties when selecting the correct antifungal medication,&#x000a0;causing delays in treatment, which is associated with poor patient outcomes and is attributed to mortality.<xref ref-type="bibr" rid="article-18810.r1">[1]</xref>&#x000a0;</p>
        <p>A novel species,<italic toggle="yes">&#x000a0;C auris,</italic>&#x000a0;first isolated in 2009 in Japan&#x000a0;<xref ref-type="bibr" rid="article-18810.r22">[22]</xref>&#x000a0;and first reported in the US in 2016,<xref ref-type="bibr" rid="article-18810.r23">[23]</xref>&#x000a0;has emerged and is alarmingly spreading in healthcare systems worldwide. This species, which has spread to 47 countries, is highly transmissible and multidrug-resistant.<xref ref-type="bibr" rid="article-18810.r24">[24]</xref> Using whole genome sequencing,&#x000a0;<italic toggle="yes">C auris</italic> has been reported to have spread almost simultaneously to different continents with the emergence of different clonal populations.<xref ref-type="bibr" rid="article-18810.r25">[25]</xref><xref ref-type="bibr" rid="article-18810.r26">[26]</xref>&#x000a0;Theories regarding the reasons behind the emergence and rapid spread of <italic toggle="yes">C auris</italic>&#x000a0;include the increasing use of antifungals and antimicrobials, climate change, healthcare worker shortages, and gaps in infection control. What is extremely worrisome is the susceptibility profile of&#x000a0;<italic toggle="yes">C auris,</italic>&#x000a0;which is multidrug- and pandrug-resistant.<xref ref-type="bibr" rid="article-18810.r26">[26]</xref>&#x000a0;<italic toggle="yes">C auris</italic> typically displays non-susceptibility to fluconazole and voriconazole, and frequently echinocandins and amphotericin B.<xref ref-type="bibr" rid="article-18810.r24">[24]</xref>&#x000a0;In the United States, 90% of&#x000a0;<italic toggle="yes">C auris</italic>&#x000a0;are resistant to fluconazole, and 30% against amphotericin B&#x02014;and the numbers are increasing.&#x000a0;Echinocandin-resistant <italic toggle="yes">C auris</italic> has also been reported and is increasing, which is worrying because echinocandins are the first-line therapy for invasive&#x000a0;<italic toggle="yes">Candida</italic>&#x000a0;infections, which include candidemia.<xref ref-type="bibr" rid="article-18810.r8">[8]</xref><xref ref-type="bibr" rid="article-18810.r26">[26]</xref><xref ref-type="bibr" rid="article-18810.r27">[27]</xref></p>
      </sec>
      <sec id="article-18810.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p><italic toggle="yes">Candida</italic>&#x000a0;spp are commensal organisms and are normally found in the gastrointestinal, vaginal, oral, and skin microbiomes.<xref ref-type="bibr" rid="article-18810.r6">[6]</xref>&#x000a0;Colonization with <italic toggle="yes">Candida</italic> spp is a prerequisite for developing invasive candidiasis and candidemia. Concomitant risk factors that can lead to candidiasis include those that allow&#x000a0;<italic toggle="yes">Candida</italic>&#x000a0;to cross the mucosal or skin barriers, those that allow it to multiply and create biofilms, and those that decrease the ability of the body to fight off infection.<xref ref-type="bibr" rid="article-18810.r28">[28]</xref>&#x000a0;These factors include the presence of indwelling vascular catheters, immunosuppression, gastrointestinal surgery (allowing translocation through the intestinal mucosa), exposure to antibiotics, and immunosuppression. Patients receiving peripheral and total parenteral nutrition and lipid emulsions are also at risk for developing candidemia.<xref ref-type="bibr" rid="article-18810.r28">[28]</xref><xref ref-type="bibr" rid="article-18810.r29">[29]</xref><xref ref-type="bibr" rid="article-18810.r30">[30]</xref></p>
      </sec>
      <sec id="article-18810.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>When evaluating any patient, it is paramount that a complete history be obtained that assesses the patient's complaints and provides an understanding of the patient's risk factors for disease. A complete physical examination should be performed on patients, especially when they have risk factors making them vulnerable to serious infections such as candidemia.<xref ref-type="bibr" rid="article-18810.r9">[9]</xref>&#x000a0;Candidemia may manifest clinically with nonspecific symptoms and physical findings. Hence, a high index of suspicion is necessary when evaluating patients with risk factors such as immunosuppression, indwelling vascular catheters (eg, port-a-caths), and antibiotic exposure.&#x000a0;&#x000a0;</p>
        <p>Candidemia most frequently occurs in patients who are hospitalized, including those in the intensive care unit, in those who are colonized with&#x000a0;<italic toggle="yes">Candida</italic>&#x000a0;spp, and who have risk factors that allow the organism to become invasive by entering their bloodstream.&#x000a0;Candidemia is not limited only to the inpatient setting; individuals in the outpatient setting can also develop candidemia, as many aspects of medical care&#x000a0;are now&#x000a0;performed as outpatients, eg, chemotherapy and indwelling vascular catheter placement. Clinicians should have a high index of suspicion and a low threshold for considering candidemia in patients with immunosuppression, especially those with neutropenia, indwelling vascular catheters, and current or previous intensive care unit stays when they&#x000a0;have&#x000a0;nonspecific symptoms, such as a simple fever, rigors, dyspnea, confusion, and hypotension.&#x000a0;</p>
        <p>Physical findings may also be&#x000a0;nonspecific, but clinicians need to be vigilant in looking for complications of candidemia. Depending on the cause of candidemia, complications such as right or left&#x000a0;<italic toggle="yes">Candida</italic>&#x000a0;endocarditis may occur,&#x000a0;and heart murmurs may be present.<xref ref-type="bibr" rid="article-18810.r9">[9]</xref>&#x000a0;The&#x000a0;site of&#x000a0;the indwelling vascular catheters should always be inspected for erythema or frank pus coming from the entry site, pointing towards an infected indwelling device. Patients who develop septic shock may develop multiorgan failure, with or without reversibility. Endocarditis may be right-sided, especially in patients with indwelling vascular catheters; this is frequently associated with valvular destruction that may require valve replacement. Endocarditis, either right or left, can also result in localized embolic phenomena depending on whether it is right or left-sided, and these emboli can go to organs (eg, the lungs, the central nervous system, and kidneys), resulting in end-organ damage. Skin lesions may be present from disseminated candidemia, especially in patients who are neutropenic. Endophthalmitis is another possible complication, and the Infectious Diseases Society of America recommends a dilated retinal examination when candidemia is diagnosed.<xref ref-type="bibr" rid="article-18810.r6">[6]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-18810.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The gold standard for diagnosing candidemia is a positive blood culture.&#x000a0;If a blood culture is positive for&#x000a0;<italic toggle="yes">Candida</italic> spp, this should always be considered an actual infection and not a contaminant. Two sets of blood cultures always need to be&#x000a0;drawn when&#x000a0;candidemia (or any other BSI) is suspected, and 1 set should always be drawn&#x000a0;through the&#x000a0;indwelling vascular catheter if present.<xref ref-type="bibr" rid="article-18810.r9">[9]</xref></p>
        <p>Unfortunately, blood cultures are limited by their poor sensitivity and slow turnaround time. Results from studies have shown that their sensitivity is only 21% to 71%, although sensitivity can be improved by increasing blood volume and drawing blood cultures more frequently.<xref ref-type="bibr" rid="article-18810.r31">[31]</xref>&#x000a0;An essential aspect of having the actual yeast grow in a blood culture is that susceptibility testing can be performed by assessing the minimum inhibitory concentration.&#x000a0;Antifungal susceptibility testing can guide targeted antifungal therapy and allow for adjustment of appropriate treatment.<xref ref-type="bibr" rid="article-18810.r9">[9]</xref></p>
        <p>Because of the low sensitivity of blood cultures for <italic toggle="yes">Candida</italic> spp, surrogate&#x000a0;markers&#x000a0;can also be&#x000a0;used to improve diagnostic accuracy. Considering all patient variables, these markers can be considered as&#x000a0;supporting evidence when culture results are not yet available in patients at high risk for candidemia. Such markers are <italic toggle="yes">Candida</italic> mannan antigen, anti-mannan antibodies, and &#x003b2;-d-glucan (BDG).<xref ref-type="bibr" rid="article-18810.r32">[32]</xref><xref ref-type="bibr" rid="article-18810.r33">[33]</xref>&#x000a0;They have the advantage of providing faster results but can have high false-positive rates. The BDG can be used as a negative predictive value.<xref ref-type="bibr" rid="article-18810.r32">[32]</xref><xref ref-type="bibr" rid="article-18810.r34">[34]</xref>&#x000a0;When evaluating a patient suspected of candidemia, 2 sets of blood cultures should be obtained. A non-culture test (eg, BDG),&#x000a0;should also be performed to enhance the diagnostic accuracy.<xref ref-type="bibr" rid="article-18810.r6">[6]</xref></p>
      </sec>
      <sec id="article-18810.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The Infectious Diseases Society of America has published guidelines and recommendations for the diagnosis and treatment of candidemia in an updated executive summary.<xref ref-type="bibr" rid="article-18810.r9">[9]</xref>&#x000a0;When evaluating patients with suspected candidemia, 2 sets of blood cultures should be performed, making sure they are also drawn from an indwelling vascular catheter, if present. Early empiric antifungal therapy should be strongly considered in those who are critically ill with risk factors for invasive candidiasis (eg, the&#x000a0;infection is suspected or confirmed, with a positive blood culture for <italic toggle="yes">Candida</italic> spp). The decision to start therapy should be based on clinical suspicion, risk factors, and surrogate markers of candidemia, such as an elevated BDG.<xref ref-type="bibr" rid="article-18810.r35">[35]</xref>&#x000a0;During therapy, it is essential to repeat blood cultures weekly to document the clearance&#x000a0;of infection.&#x000a0;</p>
        <p>Empiric therapy with an echinocandin should be the first choice when suspecting candidemia or when cultures are positive for&#x000a0;<italic toggle="yes">Candida</italic>&#x000a0;spp.<xref ref-type="bibr" rid="article-18810.r36">[36]</xref> Fluconazole may be&#x000a0;administered&#x000a0;in certain patients who are not critically ill and in those whose susceptibility to fluconazole is likely. Deescalate to fluconazole if the patient is stable after 5 to 7 days of echinocandin therapy with negative repeat blood cultures, and if the isolated&#x000a0;<italic toggle="yes">Candida</italic>&#x000a0;spp is susceptible to fluconazole.<xref ref-type="bibr" rid="article-18810.r9">[9]</xref>&#x000a0;Lipid formulation amphotericin B (AmB) can be given to patients with intolerance to other antifungals, with resistance to fluconazole or echinocandins, or when&#x000a0;other antifungals are unavailable.<xref ref-type="bibr" rid="article-18810.r6">[6]</xref>&#x000a0;De-escalating&#x000a0;from AmB to fluconazole is recommended after 5 to 7 days&#x000a0;in stable individuals whose <italic toggle="yes">Candida</italic> isolates are susceptible to fluconazole, and whose repeat blood cultures are negative.<xref ref-type="bibr" rid="article-18810.r9">[9]</xref>&#x000a0;</p>
        <p>If <italic toggle="yes">C glabrata</italic> is present, higher doses of fluconazole are recommended.&#x000a0;Similarly, if other species, such as&#x000a0;<italic toggle="yes">C parapsilosis,&#x000a0;</italic>are present<italic toggle="yes">,</italic>&#x000a0;treatment needs to be tailored to resistance patterns because <italic toggle="yes">C parapsilosis</italic> may be less susceptible to echinocandins. Depending on the patient's condition, initial therapy may need to be altered when titrating to culture results.<xref ref-type="bibr" rid="article-18810.r6">[6]</xref><xref ref-type="bibr" rid="article-18810.r37">[37]</xref>&#x000a0;A special mention is necessary for <italic toggle="yes">C kruse</italic>i because it is inherently resistant to fluconazole.</p>
        <p>Initial treatment with an azole should be considered in patients with concomitant meningitis, endophthalmitis, and urinary tract infections (due to low penetrance of echinocandins to these areas) and in patients with prior exposure to echinocandins.<xref ref-type="bibr" rid="article-18810.r6">[6]</xref>&#x000a0;Due to the emergence of antifungal resistance in <italic toggle="yes">Candida</italic> spp and the advent of multidrug-resistant <italic toggle="yes">C auri</italic>s, antifungals should be administered judiciously, with targeted therapy, de-escalation if and when susceptibility results are available, and early discontinuation when no candidemia has been identified.<xref ref-type="bibr" rid="article-18810.r6">[6]</xref><xref ref-type="bibr" rid="article-18810.r9">[9]</xref>&#x000a0;Central venous catheters should be removed as soon as possible if they are deemed the source of infection and can be safely removed.<xref ref-type="bibr" rid="article-18810.r9">[9]</xref>&#x000a0;The recommended duration of therapy for uncomplicated candidemia is&#x000a0;at least 2 weeks, especially after the indwelling catheter is removed and after the candidemia is documented to have cleared.</p>
        <p>Endocarditis needs a special mention. In the case of native valve endocarditis, a valve replacement is recommended, and treatment duration is for 6 weeks after the valve replacement, and even longer if there is a perivalvular abscess. Chronic suppression with an antifungal is recommended if the valve cannot be replaced. For prosthetic valve endocarditis or pacemaker endocarditis, removing the hardware is suggested, and 6 weeks of therapy is recommended after the removal. Chronic suppressive therapy should be considered on a case-to-case basis. Infection of the pacemaker pocket alone requires 4 weeks of antifungal therapy.<xref ref-type="bibr" rid="article-18810.r2">[2]</xref><xref ref-type="bibr" rid="article-18810.r6">[6]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-18810.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>&#x000a0;The differential diagnosis of candidemia includes the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ascending cholangitis</p>
          </list-item>
          <list-item>
            <p>Bacterial meningitis</p>
          </list-item>
          <list-item>
            <p>Bacterial sepsis</p>
          </list-item>
          <list-item>
            <p>Bacterial endocarditis</p>
          </list-item>
          <list-item>
            <p>Chronic granulomatous disease</p>
          </list-item>
          <list-item>
            <p>Cholecystitis</p>
          </list-item>
          <list-item>
            <p>Graft-versus-host disease</p>
          </list-item>
          <list-item>
            <p>Granulomatous hepatitis</p>
          </list-item>
          <list-item>
            <p>Hepatic abscess</p>
          </list-item>
          <list-item>
            <p>Tuberculosis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18810.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Candidemia is a public health concern because it is associated with poor patient outcomes, longer hospital stays, increased healthcare costs, and carries an&#x000a0;attributable mortality rate varying from 35% to 70%.<xref ref-type="bibr" rid="article-18810.r1">[1]</xref><xref ref-type="bibr" rid="article-18810.r6">[6]</xref>&#x000a0;Results from a recent study reported the 30-day overall mortality associated with candidemia to be 64%.<xref ref-type="bibr" rid="article-18810.r12">[12]</xref></p>
      </sec>
      <sec id="article-18810.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Physical findings may be&#x000a0;nonspecific, but clinicians need to be vigilant in ensuring there are no candidemia complications. Depending on the cause of candidemia, complications such as right or left&#x000a0;<italic toggle="yes">Candida</italic>&#x000a0;endocarditis may occur,&#x000a0;and heart murmurs may be present.<xref ref-type="bibr" rid="article-18810.r9">[9]</xref>&#x000a0;The&#x000a0;site of&#x000a0;the indwelling vascular catheters should always be inspected for erythema or frank pus coming from the entry site, pointing towards an infected indwelling device. Patients who develop septic shock may develop multiorgan failure, with or without reversibility. Endocarditis may be right-sided, especially in patients with indwelling vascular catheters, and this is frequently associated with valvular destruction that may require valve replacement.</p>
        <p>Endocarditis, either right or left, can also result in localized embolic phenomena depending on whether it is right or left-sided, and these emboli can go to organs, eg, the lungs, the central nervous system, and kidneys, resulting in end-organ damage. Skin lesions may be present from disseminated candidemia, especially in neutropenic patients. Endophthalmitis is another possible complication, and the Infectious Diseases Society of America recommends a dilated retinal examination when candidemia is diagnosed.<xref ref-type="bibr" rid="article-18810.r6">[6]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-18810.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Patients&#x000a0;who develop&#x000a0;candidemia usually have 1 or more&#x000a0;risk factors, including the presence of indwelling catheters, immunosuppression, antimicrobial use, intestinal mucosal surgery or breakdown, and an intensive care unit stay. These patients frequently have multiple comorbidities, are extremely ill, and&#x000a0;require consultations by various specialists. Intensive care, internal medicine, and infectious disease clinicians should be managing the treatment. Consulting infectious disease clinicians (for patients with fevers who are in the intensive care unit) has been shown to decrease mortality, is associated with earlier&#x000a0;selection of empiric or targeted antifungal therapy, provides better identification and control of the infectious source, and earlier removal of indwelling central lines when compared to patients without an infectious disease consultation.<xref ref-type="bibr" rid="article-18810.r38">[38]</xref><xref ref-type="bibr" rid="article-18810.r39">[39]</xref></p>
      </sec>
      <sec id="article-18810.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Antifungal prophylaxis is well-evidenced in patients who are neutropenic with hematological or solid organ transplantation, whereas prophylaxis with antifungals to prevent candidemia is not routinely recommended in those who are non-neutropenic and critically ill; the supporting evidence, however, is weak.<xref ref-type="bibr" rid="article-18810.r40">[40]</xref><xref ref-type="bibr" rid="article-18810.r41">[41]</xref>&#x000a0;Antifungal prophylaxis should be considered in the intensive care unit for select patients who are at the highest risk for candidemia, such as individuals with recurrent gastrointestinal perforations, anastomotic leakage, and small bowel or pancreas transplants.<xref ref-type="bibr" rid="article-18810.r42">[42]</xref></p>
      </sec>
      <sec id="article-18810.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Candidemia is a serious infection with a high mortality that must be managed promptly. The presence and involvement of an interprofessional team that includes an infectious disease physician, an intensivist, a microbiologist, intensive care nurses, and a pharmacist&#x000a0;is necessary to manage all aspects of the patient's care.&#x000a0;Patients can become quite ill, with persistent candidemia and complications such as septic shock, and the smooth collaboration of all the healthcare professionals is paramount.<xref ref-type="bibr" rid="article-18810.r43">[43]</xref><xref ref-type="bibr" rid="article-18810.r44">[44]</xref></p>
      </sec>
      <sec id="article-18810.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18810&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18810">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/candidemia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=18810">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18810/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18810">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-18810.s16">
        <title>References</title>
        <ref id="article-18810.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pappas</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Lionakis</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Arendrup</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Ostrosky-Zeichner</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kullberg</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Invasive candidiasis.</article-title>
            <source>Nat Rev Dis Primers</source>
            <year>2018</year>
            <month>May</month>
            <day>11</day>
            <volume>4</volume>
            <fpage>18026</fpage>
            <pub-id pub-id-type="pmid">29749387</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kullberg</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Arendrup</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Invasive Candidiasis.</article-title>
            <source>N Engl J Med</source>
            <year>2015</year>
            <month>Oct</month>
            <day>08</day>
            <volume>373</volume>
            <issue>15</issue>
            <fpage>1445</fpage>
            <page-range>1445-56</page-range>
            <pub-id pub-id-type="pmid">26444731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lamoth</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lockhart</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Berkow</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Calandra</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Changes in the epidemiological landscape of invasive candidiasis.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2018</year>
            <month>Jan</month>
            <day>01</day>
            <volume>73</volume>
            <issue>suppl_1</issue>
            <fpage>i4</fpage>
            <page-range>i4-i13</page-range>
            <pub-id pub-id-type="pmid">29304207</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Magill</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>O'Leary</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Janelle</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Dumyati</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nadle</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Kainer</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Lynfield</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Greissman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ray</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Beldavs</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bamberg</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sievers</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Concannon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Buhr</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Warnke</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Maloney</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ocampo</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Brooks</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Oyewumi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sharmin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Richards</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rainbow</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Samper</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hancock</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Leaptrot</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Scalise</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Badrun</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Phelps</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>JR</given-names>
              </name>
              <collab>Emerging Infections Program Hospital Prevalence Survey Team</collab>
            </person-group>
            <article-title>Changes in Prevalence of Health Care-Associated Infections in U.S. Hospitals.</article-title>
            <source>N Engl J Med</source>
            <year>2018</year>
            <month>Nov</month>
            <day>01</day>
            <volume>379</volume>
            <issue>18</issue>
            <fpage>1732</fpage>
            <page-range>1732-1744</page-range>
            <pub-id pub-id-type="pmid">30380384</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Toda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Berkow</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Farley</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Bonner</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Marceaux</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Hollick</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Schaffner</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Lockhart</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Vallabhaneni</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Population-Based Active Surveillance for Culture-Confirmed Candidemia - Four Sites, United States, 2012-2016.</article-title>
            <source>MMWR Surveill Summ</source>
            <year>2019</year>
            <month>Sep</month>
            <day>27</day>
            <volume>68</volume>
            <issue>8</issue>
            <fpage>1</fpage>
            <page-range>1-15</page-range>
            <pub-id pub-id-type="pmid">31557145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pappas</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Kauffman</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Andes</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Clancy</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Marr</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Ostrosky-Zeichner</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Reboli</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Schuster</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Vazquez</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Zaoutis</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Sobel</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.</article-title>
            <source>Clin Infect Dis</source>
            <year>2016</year>
            <month>Feb</month>
            <day>15</day>
            <volume>62</volume>
            <issue>4</issue>
            <fpage>e1</fpage>
            <page-range>e1-50</page-range>
            <pub-id pub-id-type="pmid">26679628</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Casalini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Giacomelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Antinori</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The WHO fungal priority pathogens list: a crucial reappraisal to review the prioritisation.</article-title>
            <source>Lancet Microbe</source>
            <year>2024</year>
            <month>Jul</month>
            <volume>5</volume>
            <issue>7</issue>
            <fpage>717</fpage>
            <page-range>717-724</page-range>
            <pub-id pub-id-type="pmid">38608682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lyman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Forsberg</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sexton</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Chow</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Lockhart</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Chiller</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Worsening Spread of <italic>Candida auris</italic> in the United States, 2019 to 2021.</article-title>
            <source>Ann Intern Med</source>
            <year>2023</year>
            <month>Apr</month>
            <volume>176</volume>
            <issue>4</issue>
            <fpage>489</fpage>
            <page-range>489-495</page-range>
            <pub-id pub-id-type="pmid">36940442</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pappas</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Kauffman</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Andes</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Clancy</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Marr</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Ostrosky-Zeichner</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Reboli</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Schuster</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Vazquez</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Zaoutis</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Sobel</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.</article-title>
            <source>Clin Infect Dis</source>
            <year>2016</year>
            <month>Feb</month>
            <day>15</day>
            <volume>62</volume>
            <issue>4</issue>
            <fpage>409</fpage>
            <page-range>409-17</page-range>
            <pub-id pub-id-type="pmid">26810419</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Denning</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Fungal Nomenclature: Managing Change Is the Name of the Game.</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2023</year>
            <month>Aug</month>
            <volume>10</volume>
            <issue>8</issue>
            <fpage>ofad395</fpage>
            <pub-id pub-id-type="pmid">37547850</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pfaller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Neofytos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Diekema</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Azie</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Meier-Kriesche</surname>
                <given-names>HU</given-names>
              </name>
              <name>
                <surname>Quan</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Horn</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance&#x000ae;) registry, 2004-2008.</article-title>
            <source>Diagn Microbiol Infect Dis</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>74</volume>
            <issue>4</issue>
            <fpage>323</fpage>
            <page-range>323-31</page-range>
            <pub-id pub-id-type="pmid">23102556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mete</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zerdali</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Aygun</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Saltoglu</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Balkan</surname>
                <given-names>II</given-names>
              </name>
              <name>
                <surname>Karaali</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kaya</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Karaismailoglu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kaya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Urkmez</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Can</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tabak</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ozturk</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Change in species distribution and antifungal susceptibility of candidemias in an intensive care unit of a university hospital (10-year experience).</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>325</fpage>
            <page-range>325-333</page-range>
            <pub-id pub-id-type="pmid">32935158</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tadec</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Talarmin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Gastinne</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bretonni&#x000e8;re</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Miegeville</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Le Pape</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Morio</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.</article-title>
            <source>Mycoses</source>
            <year>2016</year>
            <month>May</month>
            <volume>59</volume>
            <issue>5</issue>
            <fpage>296</fpage>
            <page-range>296-303</page-range>
            <pub-id pub-id-type="pmid">26806101</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pongr&#x000e1;cz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Juh&#x000e1;sz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Iv&#x000e1;n</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Krist&#x000f3;f</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Significance of yeasts in bloodstream infection: Epidemiology and predisposing factors of Candidaemia in adult patients at a university hospital (2010-2014).</article-title>
            <source>Acta Microbiol Immunol Hung</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>317</fpage>
            <page-range>317-29</page-range>
            <pub-id pub-id-type="pmid">26551574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carmon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rimon</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>HR</given-names>
              </name>
            </person-group>
            <article-title>Candida sepsis during total parenteral nutrition: An endogenous infection indicating the severity of patients' disease state.</article-title>
            <source>Clin Nutr</source>
            <year>1992</year>
            <month>Aug</month>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>240</fpage>
            <page-range>240-3</page-range>
            <pub-id pub-id-type="pmid">16840003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pfaller</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Diekema</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Turnidge</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Castanheira</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>RN</given-names>
              </name>
            </person-group>
            <article-title>Twenty Years of the SENTRY Antifungal Surveillance Program: Results for <italic>Candida</italic> Species From 1997-2016.</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>6</volume>
            <issue>Suppl 1</issue>
            <fpage>S79</fpage>
            <page-range>S79-S94</page-range>
            <pub-id pub-id-type="pmid">30895218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berkow</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Lockhart</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Fluconazole resistance in <italic>Candida</italic> species: a current perspective.</article-title>
            <source>Infect Drug Resist</source>
            <year>2017</year>
            <volume>10</volume>
            <fpage>237</fpage>
            <page-range>237-245</page-range>
            <pub-id pub-id-type="pmid">28814889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aguilar</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Delgado</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Corrales</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Izquierdo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gracia</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Romero</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ferrando</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Carbonell</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Borr&#x000e1;s</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Navarro</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Belda</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study.</article-title>
            <source>BMC Res Notes</source>
            <year>2015</year>
            <month>Sep</month>
            <day>29</day>
            <volume>8</volume>
            <fpage>491</fpage>
            <pub-id pub-id-type="pmid">26415526</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chapman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Slavin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marriott</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Halliday</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kidd</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Arthur</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bak</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Heath</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Morrissey</surname>
                <given-names>CO</given-names>
              </name>
              <name>
                <surname>Sorrell</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>van Hal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Keighley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Goeman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Underwood</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hajkowicz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hofmeyr</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Macesic</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Botes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Blyth</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cooley</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>George</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Kalukottege</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kesson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McMullan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Baird</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Robson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Korman</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Pendle</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Weeks</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cheong</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>S</given-names>
              </name>
              <collab>Australian and New Zealand Mycoses Interest Group</collab>
            </person-group>
            <article-title>Changing epidemiology of candidaemia in Australia.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2017</year>
            <month>Apr</month>
            <day>01</day>
            <volume>72</volume>
            <issue>4</issue>
            <fpage>1103</fpage>
            <page-range>1103-1108</page-range>
            <pub-id pub-id-type="pmid">28364558</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rogers</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Verweij</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Castanheira</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dannaoui</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Arendrup</surname>
                <given-names>MC</given-names>
              </name>
              <collab>Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST)</collab>
            </person-group>
            <article-title>Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2022</year>
            <month>Jul</month>
            <day>28</day>
            <volume>77</volume>
            <issue>8</issue>
            <fpage>2053</fpage>
            <page-range>2053-2073</page-range>
            <pub-id pub-id-type="pmid">35703391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doi</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Pignatari</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Edmond</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Marra</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Camargo</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Siqueira</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>da Mota</surname>
                <given-names>VP</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program.</article-title>
            <source>PLoS One</source>
            <year>2016</year>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>e0146909</fpage>
            <pub-id pub-id-type="pmid">26808778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Satoh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Makimura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hasumi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nishiyama</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Uchida</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yamaguchi</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital.</article-title>
            <source>Microbiol Immunol</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>53</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-4</page-range>
            <pub-id pub-id-type="pmid">19161556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vallabhaneni</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kallen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tsay</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chow</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Welsh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kerins</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kemble</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Pacilli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Landon</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ridgway</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Palmore</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Zelzany</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Quinn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chaturvedi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Greenko</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fernandez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Southwick</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Furuya</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Calfee</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Hamula</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lafaro</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Berkow</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Moulton-Meissner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Noble-Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fagan</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Lockhart</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Litvintseva</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Chiller</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus-United States, May 2013-August 2016.</article-title>
            <source>Am J Transplant</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>296</fpage>
            <page-range>296-299</page-range>
            <pub-id pub-id-type="pmid">28029734</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benedict</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Forsberg</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gold</surname>
                <given-names>JAW</given-names>
              </name>
              <name>
                <surname>Baggs</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lyman</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Candida auris&#x02012;Associated Hospitalizations, United States, 2017-2022.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2023</year>
            <month>Jul</month>
            <volume>29</volume>
            <issue>7</issue>
            <fpage>1485</fpage>
            <page-range>1485-1487</page-range>
            <pub-id pub-id-type="pmid">37347923</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lockhart</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Etienne</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Vallabhaneni</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Farooqi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chowdhary</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Govender</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Calvo</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cuomo</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Desjardins</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Berkow</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Castanheira</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Magobo</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Jabeen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Asghar</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Meis</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chiller</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Litvintseva</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.</article-title>
            <source>Clin Infect Dis</source>
            <year>2017</year>
            <month>Jan</month>
            <day>15</day>
            <volume>64</volume>
            <issue>2</issue>
            <fpage>134</fpage>
            <page-range>134-140</page-range>
            <pub-id pub-id-type="pmid">27988485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mishra</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Yasir</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Willcox</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Candida auris: an emerging antimicrobial-resistant organism with the highest level of concern.</article-title>
            <source>Lancet Microbe</source>
            <year>2023</year>
            <month>Jul</month>
            <volume>4</volume>
            <issue>7</issue>
            <fpage>e482</fpage>
            <page-range>e482-e483</page-range>
            <pub-id pub-id-type="pmid">37119824</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacobs</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Dennis</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Taimur</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gitman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schaefer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Iyer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Moon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lerner</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Anower</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Vaidya</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Chaturvedi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chaturvedi</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2022</year>
            <month>Jul</month>
            <day>19</day>
            <volume>66</volume>
            <issue>7</issue>
            <fpage>e0005322</fpage>
            <pub-id pub-id-type="pmid">35770999</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zuo</surname>
                <given-names>XS</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and risk factors of candidemia due to Candida parapsilosis in an intensive care unit.</article-title>
            <source>Rev Inst Med Trop Sao Paulo</source>
            <year>2021</year>
            <volume>63</volume>
            <fpage>e20</fpage>
            <pub-id pub-id-type="pmid">33787740</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pappo</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Polacheck</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Zmora</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Feigin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>HR</given-names>
              </name>
            </person-group>
            <article-title>Altered gut barrier function to Candida during parenteral nutrition.</article-title>
            <source>Nutrition</source>
            <year>1994</year>
            <season>Mar-Apr</season>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>151</fpage>
            <page-range>151-4</page-range>
            <pub-id pub-id-type="pmid">8025369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Swindell</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lattif</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Chandra</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mukherjee</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Ghannoum</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Parenteral lipid emulsion induces germination of Candida albicans and increases biofilm formation on medical catheter surfaces.</article-title>
            <source>J Infect Dis</source>
            <year>2009</year>
            <month>Aug</month>
            <day>01</day>
            <volume>200</volume>
            <issue>3</issue>
            <fpage>473</fpage>
            <page-range>473-80</page-range>
            <pub-id pub-id-type="pmid">19552524</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clancy</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care.</article-title>
            <source>Clin Infect Dis</source>
            <year>2013</year>
            <month>May</month>
            <volume>56</volume>
            <issue>9</issue>
            <fpage>1284</fpage>
            <page-range>1284-92</page-range>
            <pub-id pub-id-type="pmid">23315320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clancy</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Non-Culture Diagnostics for Invasive Candidiasis: Promise and Unintended Consequences.</article-title>
            <source>J Fungi (Basel)</source>
            <year>2018</year>
            <month>Feb</month>
            <day>19</day>
            <volume>4</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">29463043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic value of Candida mannan antigen and anti-mannan IgG and IgM antibodies for Candida infection.</article-title>
            <source>Mycoses</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>63</volume>
            <issue>2</issue>
            <fpage>181</fpage>
            <page-range>181-188</page-range>
            <pub-id pub-id-type="pmid">31755600</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duettmann</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Koidl</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Krause</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lackner</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Woelfler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hoenigl</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Specificity of mannan antigen and anti-mannan antibody screening in patients with haematological malignancies at risk for fungal infection.</article-title>
            <source>Mycoses</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>59</volume>
            <issue>6</issue>
            <fpage>374</fpage>
            <page-range>374-8</page-range>
            <pub-id pub-id-type="pmid">26916753</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lamoth</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Akan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Andes</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cruciani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marchetti</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Ostrosky-Zeichner</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Racil</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Clancy</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Assessment of the Role of 1,3-&#x003b2;-d-Glucan Testing for the Diagnosis of Invasive Fungal Infections in Adults.</article-title>
            <source>Clin Infect Dis</source>
            <year>2021</year>
            <month>Mar</month>
            <day>12</day>
            <volume>72</volume>
            <issue>Suppl 2</issue>
            <fpage>S102</fpage>
            <page-range>S102-S108</page-range>
            <pub-id pub-id-type="pmid">33709130</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tang</surname>
                <given-names>BHE</given-names>
              </name>
              <name>
                <surname>Bay</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Yeong</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Samuel</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Efficacy and safety of echinocandin monotherapy and combination therapy for immunocompromised patients with systemic candidiasis: A systematic review and meta-analysis.</article-title>
            <source>J Mycol Med</source>
            <year>2023</year>
            <month>May</month>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>101362</fpage>
            <pub-id pub-id-type="pmid">36867970</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ning</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Perlin</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Dai</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Decreased echinocandin susceptibility in <italic>Candida parapsilosis</italic> causing candidemia and emergence of a pan-echinocandin resistant case in China.</article-title>
            <source>Emerg Microbes Infect</source>
            <year>2023</year>
            <month>Dec</month>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>2153086</fpage>
            <pub-id pub-id-type="pmid">36440795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Speight</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Williamson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Ebied</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Medaris</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>McCurdy</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hammer</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Impact of Infectious Diseases Consultation in Patients With Candidemia at a Multisite Health Care System With Established Antimicrobial Stewardship and Telemedicine Services.</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2023</year>
            <month>Aug</month>
            <volume>10</volume>
            <issue>8</issue>
            <fpage>ofad388</fpage>
            <pub-id pub-id-type="pmid">37555131</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kobayashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Marra</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Schweizer</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Ten Eyck</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Alzunitan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Salinas</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Farmakiotis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Auwaerter</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Healy</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Diekema</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Impact of Infectious Disease Consultation in Patients With Candidemia: A Retrospective Study, Systematic Literature Review, and Meta-analysis.</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>7</volume>
            <issue>9</issue>
            <fpage>ofaa270</fpage>
            <pub-id pub-id-type="pmid">32904995</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Primary Fungal Prophylaxis in Hematological Malignancy: a Network Meta-Analysis of Randomized Controlled Trials.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>62</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">29866872</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maertens</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Girmenia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Br&#x000fc;ggemann</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Duarte</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Kibbler</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Ljungman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Racil</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Ribaud</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Slavin</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Cornely</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Peter Donnelly</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cordonnier</surname>
                <given-names>C</given-names>
              </name>
              <collab>European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and</collab>
              <collab>European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN)</collab>
            </person-group>
            <article-title>European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2018</year>
            <month>Dec</month>
            <day>01</day>
            <volume>73</volume>
            <issue>12</issue>
            <fpage>3221</fpage>
            <page-range>3221-3230</page-range>
            <pub-id pub-id-type="pmid">30085172</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bassetti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Giacobbe</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Vena</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wolff</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Treatment of Candidemia in the Intensive Care Unit.</article-title>
            <source>Semin Respir Crit Care Med</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>40</volume>
            <issue>4</issue>
            <fpage>524</fpage>
            <page-range>524-539</page-range>
            <pub-id pub-id-type="pmid">31585478</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dudoignon</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Alanio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Anstey</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Depret</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Coutrot</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fratani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jully</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cupaciu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chaussard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oueslati</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ferry</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Benyamina</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de Tymowski</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Boccara</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Serror</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chaouat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mimoun</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lafaurie</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Denis</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gits-Muselli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bretagne</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mebazaa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Legrand</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Soussi</surname>
                <given-names>S</given-names>
              </name>
              <collab>PRONOBURN group</collab>
            </person-group>
            <article-title>Outcome and potentially modifiable risk factors for candidemia in critically ill burns patients: A matched cohort study.</article-title>
            <source>Mycoses</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>237</fpage>
            <page-range>237-246</page-range>
            <pub-id pub-id-type="pmid">30478963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18810.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jia</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics and predictors of mortality in patients with candidemia: a six-year retrospective study.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>37</volume>
            <issue>9</issue>
            <fpage>1717</fpage>
            <page-range>1717-1724</page-range>
            <pub-id pub-id-type="pmid">30030692</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
